Carmelo Gurnari

Carmelo Gurnari, MD, PhD, is a dedicated hematologist currently serving as a Research Associate in the Department of Translational Hematology and Oncology Research at the Cleveland Clinic (USA) and as an Assistant Professor of Hematology at the University of Tor Vergata in Rome, Italy.

Dr. Gurnari earned his medical degree from the University of Pavia, Italy, in 2015, and completed his Hematology training at Tor Vergata University in 2020. He joined the Cleveland Clinic in 2019, where he also completed a Ph.D. in "Immunology, Molecular Medicine, and Applied Biotechnology," subsequently being appointed to the faculty.

His long-term research interests focus on unraveling the ontogenetic mechanisms of leukemia using cutting-edge molecular biology sequencing platforms, with the ultimate goal of informing early therapeutic interventions. Specifically, he studies the genomics of bone marrow failure disorders and myeloid neoplasia, including germline predisposition, while pioneering efforts to translate genomic information into clinical practice.

Dr. Gurnari has made significant contributions to his field, having authored over 150 papers in prestigious journals. He has secured national and international grants from organizations such as the EvansMDS Foundation, the American-Italian Cancer Foundation, and the European Hematology Association. Additionally, he has received several accolades, including the Tito Bastianello Prize at the 2021 International MDS Symposium and the ASH-IPIG Award on two occasions.

https://evansmds.org/gurnari-carmelo-m-d/

https://www.researchgate.net/profile/Carmelo-Gurnari